| 1 |
33747208 | A drug targeting 5-lipoxygenase enhances the activity of a JAK2 inhibitor in CD34+ bone marrow cells from patients with JAK2V617F-positive polycythemia vera in vitro. | 2021 May |
1 |
| 2 |
34638347 | Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis. | 2021 Sep 28 |
1 |
| 3 |
28042144 | Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells. | 2017 Sep |
1 |
| 4 |
26115187 | Dynamics of JAK2 V617F allele burden of CD34+ haematopoietic progenitor cells in patients treated with ruxolitinib. | 2016 Feb |
1 |
| 5 |
25805962 | Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A. | 2015 |
1 |
| 6 |
26227854 | Targeting glutamine metabolism in myeloproliferative neoplasms. | 2015 Oct |
1 |